AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Escitalopram Oxalate in South Africa
6 products registered with SAHPRA — 3 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| ESCITALOPRAM BE-TABS 5 | 41/1.2/0401 | Cipla Medpro (Pty) Ltd | suspended | 17 Jul 2025 |
| ESCITALOPRAM BE-TABS 10 | 41/1.2/0402 | Cipla Medpro (Pty) Ltd | suspended | 17 Jul 2025 |
| ESCITALOPRAM BE-TABS 20 | 41/1.2/0403 | Cipla Medpro (Pty) Ltd | suspended | 17 Jul 2025 |
| LEXAMIL 10 | 41/1.2/0395 | Cipla Medpro (Pty) Ltd | active | 1 Jan 1900 |
| LEXAMIL 5 | 41/1.2/0394 | Cipla Medpro (Pty) Ltd | active | 1 Jan 1900 |
| LEXAMIL 20 | 41/1.2/0396 | Cipla Medpro (Pty) Ltd | active | 1 Jan 1900 |
Escitalopram Oxalate — SAHPRA Registration Details
SAHPRA (South Africa) has 6 registered products containing Escitalopram Oxalate, of which 3 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Escitalopram Oxalate registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.